Streetwise Reports' Article Archives — August 2019 back to current month (26)

Lannett Signs Exclusive U.S. Distribution Deal with Sinotherapeutics; Shares Up 40% (08/28/2019)

Shares of Lannett Co. are up 40% today after announcing that it secured rights to be the exclusive U.S. distributor of Sinotherapeutics' antifungal drug that is an AB-rated generic for Noxafil.

more>

FDA Approves First-of-Its-Kind, Adult Pneumonia Antibiotic; September Launch Planned (08/27/2019)

The drug's features and its developer's commercial plans are discussed in an H.C. Wainwright & Co. report.

more>

After Biotech Dives Deeper Into Melanoma Data, It 'Continues to Impress' (08/27/2019)

Details from this clinical program are discussed, along with Q2/19 earnings and the next stock catalyst, in an H.C. Wainwright & Co. report.

more>

'Topline Beat, All Eyes on Potential M&A' by Health Technologies Firm (08/27/2019)

An update on the Canadian company, including its Q2/19 results and its next expected catalyst, is provided in a Haywood report.

more>

Developer of Premix for Livestock Feed Lands Sizable Order from Asia (08/26/2019)

Demand for the Canadian company's product is growing in the Asia-Pacific region.

more>

Why Provention Bio Is in My Portfolio (08/23/2019)

Orphan drug and breakthrough therapy status, which could mean this company's lead candidate is on the FDA fast track, translates to huge opportunities for both those suffering from diabetes and investors, says Daniel Carlson of Tailwinds Research.

more>

Retrophin Shares Fall 30% on Failed Phase 3 FORT Study (08/22/2019)

Shares of Retrophin fell to a 52-week low on the news that topline results from its fosmetpantotenate Phase 3 FORT Study for PKNA treatment failed to meet expectations.

more>

Small-Cap Logistics Company Partners with Aphria to Deliver Medical Cannabis (08/22/2019)

The initiative, to start in Calgary, is expected to expand rapidly into other cities.

more>

Life Sciences Firm's OxC-beta Approved for Livestock Feed in Mexico (08/21/2019)

The country represents a significant market for feed consumption.

more>

'Data Readouts Approaching in Two Pivotal Trials' for Biopharma Targeting Unmet Needs (08/20/2019)

The next steps for each of the programs are outlined in a Dawson James Securities report.

more>

Medtronic Stock Hits All-Time High After Raising 2020 EPS Outlook (08/20/2019)

Dublin-based Medtronic reported Q1/20 earnings and revised its full-year earnings outlook upward sending shares up more than 5% today.

more>

A Potential CBD Processor with 'Blue-Sky Prospects' (08/20/2019)

Peter Epstein of Epstein Research speaks with Martin Doane, CEO of Leviathan Cannabis Group, about the company's international plans to grow hemp and produce a hemp-derived CBD isolate and what sets the company apart from its peers.

more>

Analyst Upgrade Ignites Duchenne's Muscular Dystrophy Research Firm's Shares (08/16/2019)

Solid Biosciences' shares are up by more than 40% today after Chardan Capital Markets upgraded the firm's shares from "neutral" to "buy" and raised its price target from $7.50 to $10.00/share.

more>

InMode Reports Solid Q2 Earnings and Appoints Paula Abdul as Brand Ambassador (08/14/2019)

InMode Ltd. reported Q2/19 earnings and announced that international pop superstar Paula Abdul will be its brand ambassador sending shares "Straight Up" 15% as investors "Rush Rush" to purchase shares today.

more>

Deciphera's Shares Open 115% Higher on Phase 3 Ripretinib Results (08/13/2019)

Deciphera Pharmaceuticals announced positive top-line results from the INVICTUS pivotal phase 3 clinical study of ripretinib in patients with advanced gastrointestinal stromal tumors.

more>

Biotech's DMD Therapeutic 'Solidifies the Ground for Potential Pivotal Design' (08/12/2019)

The latest development concerning this clinical asset and other Q2/19 highlights are provided in an H.C. Wainwright & Co. report.

more>

Amgen Shares React Favorably to Enbrel Patent Case Victory (08/12/2019)

Amgen shares are trading 56% higher today on news that the company has won its Enbrel (etanercept) patent court case.

more>

Puma Biotech Shares Up More Than 20% on Q2 Earnings and Breast Cancer Drug Sales (08/09/2019)

Shares in Puma Biotechnology are trading 20% higher today after the company released Q2/19 earnings and reported positive NERLYNX revenue growth.

more>

Avedro Shares Looking Up 35% with Glaukos Merger (08/08/2019)

Avedro Inc. and Glaukos Corp. announced that the firms' boards of directors have executed a definitive merger agreement. The all-stock deal is expected to close in Q4/19.

more>

Guardant Health Reports Quarterly Revenue Up 178% (08/07/2019)

Guardant Health Inc. reported strong growth for Q2/19 versus the same period last year and raised its full-year 2019 revenue guidance to $180190 million.

more>

Allakos Shares Double on AK002 Phase 2 Results and Earnings (08/05/2019)

Allakos Inc. shares are soaring today as the company reported Q2/19 earnings and announced positive results from its phase 2 study for its AK002 inhibitor used in the treatment of eosinophil and mast cell related diseases.

more>

Biotech 'Thinking Several Steps Ahead with Optimizing IVR Quality Control' (08/02/2019)

The company's latest science, presented at a recent conference, is discussed in a ROTH Capital Partners report.

more>

Biotech's Mosquito Test 'Gains Market Acceptance' (08/02/2019)

This West Nile virus test and others including cancer diagnostic tests in the Utah company's pipeline are discussed in an H.C. Wainwright & Co. report.

more>

Tandem Increases Unit Sales of t:slim X2 Insulin Pumps 290% Worldwide (08/02/2019)

Tandem Diabetes Care's second quarter earnings highlighted a 290% increase in unit sales of its t:slim X2 insulin pumps that feature integrated continuous glucose monitoring and remote software update capability.

more>

Gaia Grow Corp. Plants 1,494 Acres of Hemp in Canada and Plans First Harvest in 2 Months (08/01/2019)

Gaia Grow Corp. CEO Frederick Pels speaks with Peter Epstein of Epstein Research on the day his company begins trading on the TSX Venture Exchange.

more>

Led by Sales of HETLIOZ, Vanda Increases Quarterly Revenues by 25% (08/01/2019)

Shares of Vanda Pharmaceuticals traded nearly 30% higher after the company released Q2/19 earnings and positive sales trends for both HETLIOZ and Fanapt.

more>

More Archives

2019Sep Aug Jul Jun May Apr Mar Feb Jan

2018Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2017Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2016Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2015Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2014Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

Get Our Streetwise Reports Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe

Notable Quotes